Tuesday 18 October 2016: Pre-Conference Workshops

Workshops for EFIB 2017 will be announced early next year. If you would like to host a workshop, please contact georgia.atwal@smithers.com.

Workshop A - SynBio

Introduction to SynBIo

  1. Registration

  2. Chair's opening remarks

    John Cumbers | Founder of SynBioBeta

    John Cumbers, SynBioBeta
  3. A Short Introduction to Synthetic Biology and RTD Activities at the University of Edinburgh

    Susan Rosser | Professor of Synthetic Biology of University of Edinburgh

  4. Exploring the what, where and how of SynBio

    Ian Archer | Technical Director ofioIC

    • What is synthetic biology?
    • How can you take advantage of it multidisciplinarity?
    • Exploring the platform technology
    • Identifying the industrial and market sectors impacted
    • Assessing the technology trajectories

    Ian Archer, Technical Director, IBioIC

  5. Why is synbio important to industry?

    US National Academy of Sciences representative Rick Johnson leads this session

    Rick Johnson is a member of the US National Academy of Sciences and contributed to the US strategy for the ‘Industrialization of Biology’ and he’s the Chair of the OECD’s Business and Industry Advisory Committee.  As such he has an excellent perspective of international government and industry strategies and policies with regards to advanced technologies, including synbio.

European success stories

Hear from front-running companies who are making significant progress in IB SynBio development to understand the technologies and processes that are being commercialised.  

  1. The commercial application of synthetic promoters

    Dr David Venables | CEO of Synpromics Ltd

  2. Growing a synthetic biology startup in the UK

    Dr James Field | CEO and Founder of LabGenius

    LabGenius is a London-based synthetic biology startup that specialises in the manufacture of synthetic DNA libraries. In this talk, LabGenius' founder James Field will share his experiences in growing the company and taking their first product to market. 

  3. The development and commercial exploitation of Clostridium for high value products

    Dr Edward Green | Chief Executive of CHAIN Biotechnology Ltd.

  4. Biotangents: Applying synthetic biology to meet diagnostic challenges in animal health

    Dr Andy Hall-Ponsele | Director and Lead Scientist of Biotangents Limited

    Biotangents was founded by Lead Scientists Andy Hall-Ponsele and Lina Gasiunaite in 2015 to develop DNA manipulation technologies and apply them to meet economic challenges. We have recently been awarded funding from SynbiCITE to develop a point-of-care solution for bovine tuberculosis (TB) diagnosis in cattle. Bovine TB costs the UK government £100 million each year and the global economy $3 billion, and it is a significant barrier to the free trade of livestock. Current diagnostic tests lack specificity, sensitivity and immediacy. Our innovation is a highly specific, sensitive and cost-effective device for on-site diagnosis. It is based on Moduleic Sensing™, our modular cell-free nucleic acid sensing technology, and is further underpinned by our Short Sequence Randomisation™ and Leapfrog Assembly™ DNA technologies. Moduleic Sensing™ is specifically designed to allow individual sensor components to be redesigned with maximum ease, with the result that the time and costs of adapting our devices to new diagnostic targets are minimised. Through Moduleic Sensing™, Biotangents will deliver practical and cost-effective point-of-care diagnostics and monitoring for animal health.

  5. Networking Break

Global developments and discussion

  1. Global developments – perspective of SynBioBeta in US, EU and China

    Led by the Founder of the leading global membership association and network for synbio

    John Cumbers, SynBioBeta

    John Cumbers is the founder of SynBioBeta which is without doubt the leading global membership association and network for synbio.  Their events attract all the leading synbio companies and researchers, as well as investors, from all over the globe.  They have organised missions to synbio clusters across the US, China and Europe and are based in the heartland of synbio- San Francisco.  There’s not much that John doesn’t know about what is happening in synbio in terms of industry development and investment strategies.

  2. Closing Q&A with the Masterclass expert speakers

    Take this opportunity to get your questions answered by our Masterclass experts in this closing Q&A panel.

    Moderated by: John Cumbers, Founder, SynBioBeta


    Ian Archer, Technical Director, IBioIC

    Richard A. Johnson, CEO, Global Helix LLC and Member, National Academy of Sciences Board on Life Sciences

    Dr David Venables, CEO, Synpromics Ltd

    Dr James Field, CEO, LabGenius

    Dr Edward Green, Founder and Chief Executive, CHAIN Biotechnology Ltd

    Dr Andy Hall-Ponsele, Director and Lead Scientist, Biotangents Limited

  3. Chair's closing remarks

  4. Welcome reception in Exhibition Hall

Workshop B - Waste Biorefinery

Urban organic waste

  1. Registration

  2. Chair's opening remarks

    David Newman | Managing Director of Bio-based and Biodegradable Industries Association (BBIA)

  3. The biorefinery opportunity for urban organic wastes

    Dr Mark Gronnow | Process Development Unit Manager of Biorenewables Development Centre

  4. Creating value from a waste liability: Production of high-value chemicals and biofuel from the biogenic fraction of autoclaved MSW

    Sheila Hughes | Sales and Marketing Manager of Wilson Bio-Chemical

    Wilson Bio-Chemical has spent the last 16 years developing a system for the conversion of the biogenic fraction of MSW and commercial waste into assets and high value chemical using autoclaving techniques.

    MSW worldwide is a sustainable and plentiful source of material for the production of bio products but it’s in built heterogeneous character makes it very difficult to handle. Autoclaving the waste beforehand at medium temperatures sanitises and homogenises the material making it much easier to handle in subsequent processes.

  5. Conversion of agrifood chain wastes to ingredients, fuels and chemicals

    Prof Keith Waldron | Director of Biorefinery Centre, Institute for Food Research

  6. Moving the regulatory goalposts to meet the needs of a biowaste-based bioeconomy

    Dr David Tompkins | Bioresources Development Manager of Aqua Enviro

    The UK’s environmental regulators have worked hard to define standardised end of waste positions for a variety of materials – most notably compost and digestate.  However, while these have proven sufficient to stimulate market uptake of these materials, they do not encompass basic valorisation options such as ammonia stripping or struvite precipitation.  Although bespoke end of waste positions can be developed, the time and resource necessary to achieve these could deter SME’s interested in using biowaste as the base material for novel valorisation processes.  Using digestate as an example, this presentation will outline the current approach and propose a framework for the future.

  7. Structured discussion groups

    David Newman | Managing Director of Bio-based and Biodegradable Industries Association (BBIA)

    Delegates will break into small groups to identify the top 3, regulatory, technical, economic and logistical barriers to use of organic urban waste as an IB feedstock, the solutions to these barriers and who needs to do what to develop the solutions.

    Facilitated by: David Newman, Managing Director, BBIA

  8. Networking Break

Agricultural by-products

  1. Chair's opening remarks

    Dr Willem Sederel | Board Member of Biobased Delta

  2. Vireol: The straw-based biorefinery

    Ged Russell | Technical Director of Vireol Bio-industries plc

  3. Sustainable insect protein production as feed for fish and fowl

    Adrian Charlton | Head of Chemical and Biochemical Profiling, The Food and Environment Research Agency (FERA)

  4. Use of Biobased aromatics in industrial polymers

    Elena Benedetti | Director of Product Application of AEP Polymers

    Aromatic organic materials are often recovered as byproduct or waste stream of agricultural and industrial processes. Some of the collected materials are not edible and may not be reused in agricultural processes and are used as an energy source or disposed of. The presentation shows the potential for chemical purification and functionalization or aromatic molecules and their use in the polymer industry. Biobased resins are in fact an emerging alternative for performance materials and the new generation biopolymers re required to improve both sustainability and technical aspects. AEP has been working with RTOs and industrial partners to create brand new substances and materials starting from renewable resources and combining different chemical structures, from fatty acids to bio aromatics. In particular, Cashew Nut Shell Liquid (CNSL) is a naturally occurring source of phenols. AEP developed a portfolio of industrial polymers from CNSL to deliver performing materials for demanding industrial applications in composites, polyurethanes and adhesives.

  5. Agrimax valorisation

    Arno van de Kant | Business Development Manager of Bioprocess Pilot Facility B.V.

    For the economic and environmental sustainability for the AGRIcultural and food businesses to be MAXimised in Europe while providing new biocompounds to the chemical, bioplastic, food, fertilizers, packaging and agriculture materials sectors, the overriding goal of AgriMax is to demonstrate the technical and economic feasibility of these new applications for the agricultural Value chains cooperativising biorefinery processes for valorising crops & food processing derived wastes

  6. Structured discussion groups

    Dr Willem Sederel | Board Member of Biobased Delta

    Delegates break into small groups to identify the top 3, regulatory, technical, economic and logistical barriers to use of agricultural waste as an IB feedstock, the solutions to these barriers and who needs to do what to develop the solutions.

    Facilitated by: Willem Sederel, Member of the Board, Biobased Delta

  7. Plenary report back by rapporteurs

  8. Discussion of policy recommendations identified in each workshop

    Each workshop will have an experienced rapporteur who will record the key findings of the discussion. These will be written up after the workshop into a workshop report and a policy brief that will be circulated to participants before dissemination to relevant policy makers.

  9. Welcome reception in Exhibition Hall